SREBF1 and Insulin resistance: Insulin resistance can then lead to lipoprotein lipase inhibition and SREBP-1c stimulation causing increased LDL-C and triglyceride levels, respectively [8,9]. These pathways, coupled with the disrupted genetic regulation of lipid metabolism, cause enhanced lipogenesis in the liver and decrease lipid clearance from the bloodstream [10,11].